PapersFlow Research Brief
Sphingolipid Metabolism and Signaling
Research Guide
What is Sphingolipid Metabolism and Signaling?
Sphingolipid metabolism and signaling refers to the biochemical pathways involving the synthesis, breakdown, and signal transduction roles of sphingolipids such as sphingosine-1-phosphate and ceramide, which regulate cellular processes including lymphocyte egress, insulin resistance, cancer, and apoptosis.
Sphingolipid metabolism and signaling encompasses over 32,051 published works in molecular biology. These studies examine sphingolipids like sphingosine-1-phosphate and ceramide in membrane organization and cellular signaling. Key research highlights their roles in health and disease, including lymphocyte trafficking and immune modulation.
Topic Hierarchy
Research Sub-Topics
Sphingosine-1-Phosphate Signaling
This sub-topic investigates S1P receptors and their roles in cell migration, vascular development, and immune responses. Researchers explore therapeutic modulation using agonists like FTY720.
Ceramide-Mediated Apoptosis
This sub-topic examines ceramide generation and its activation of death pathways in response to stress signals. Researchers study enzymes like ceramide synthases and inhibitors in cancer contexts.
Sphingolipid Metabolism Dysregulation
This sub-topic focuses on imbalances in sphingolipid enzymes leading to insulin resistance and metabolic syndrome. Researchers analyze sphingomyelinase and kinase activities in obesity models.
Lipid Rafts in Sphingolipid Signaling
This sub-topic explores sphingolipid-enriched membrane domains organizing receptor signaling complexes. Researchers probe raft dynamics and their disruption in disease.
Sphingosine Kinase Regulation
This sub-topic studies isoforms of sphingosine kinases, their activation, and inhibitors in inflammation and cancer. Researchers investigate post-translational controls and pharmacological targeting.
Why It Matters
Sphingolipid metabolism and signaling impacts multiple sclerosis treatment through fingolimod (FTY720), a sphingosine-1-phosphate analog. Kappos et al. (2010) in "A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis" showed that oral fingolimod reduced relapse rates and disability progression risk compared to placebo in a clinical trial (NCT00289978). Cohen et al. (2010) in "Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis" demonstrated fingolimod's superior efficacy over intramuscular interferon beta-1a in reducing relapses and improving MRI outcomes. Matloubian et al. (2004) in "Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1" established that S1P receptor 1 controls lymphocyte egress from lymphoid organs. Hannun and Obeid (2008) in "Principles of bioactive lipid signalling: lessons from sphingolipids" outlined sphingolipids' roles in apoptosis and cancer, with ceramide promoting cell death pathways.
Reading Guide
Where to Start
"Principles of bioactive lipid signalling: lessons from sphingolipids" by Hannun and Obeid (2008), as it provides foundational principles of sphingolipid signaling applicable to health and disease contexts.
Key Papers Explained
Hannun and Obeid (2008) in "Principles of bioactive lipid signalling: lessons from sphingolipids" establish core signaling mechanisms of sphingolipids like ceramide and S1P. Spiegel and Milstien (2003) in "Sphingosine-1-phosphate: an enigmatic signalling lipid" expand on S1P's specific roles in cell regulation. Matloubian et al. (2004) in "Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1" applies these to lymphocyte trafficking. Kappos et al. (2010) in "A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis" and Cohen et al. (2010) in "Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis" demonstrate clinical translation via fingolimod trials.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes therapeutic modulation of S1P receptors in autoimmunity, as seen in multiple sclerosis trials. Lipid raft dynamics in signaling remain active, building on Simons and Toomre (2000) and Brown and London (1998). No recent preprints or news reported in the last six to twelve months.
Papers at a Glance
Frequently Asked Questions
What role does S1P receptor 1 play in lymphocyte trafficking?
S1P receptor 1 regulates lymphocyte egress from the thymus and peripheral lymphoid organs. Matloubian et al. (2004) in "Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1" showed that its activation is required for lymphocytes to exit these tissues into circulation. This mechanism underlies the action of fingolimod in retaining lymphocytes in lymphoid organs.
How does fingolimod treat multiple sclerosis?
Fingolimod, an oral sphingosine-1-phosphate analog, reduces relapse rates and MRI lesion activity in relapsing multiple sclerosis. Kappos et al. (2010) in "A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis" reported improved outcomes versus placebo across two doses. Cohen et al. (2010) in "Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis" confirmed its superiority over interferon beta-1a.
What are the signaling principles of sphingolipids?
Sphingolipids like ceramide and sphingosine-1-phosphate act as bioactive lipids in signaling pathways controlling cell growth, death, and stress responses. Hannun and Obeid (2008) in "Principles of bioactive lipid signalling: lessons from sphingolipids" detailed their roles in apoptosis and inflammation. Spiegel and Milstien (2003) in "Sphingosine-1-phosphate: an enigmatic signalling lipid" described S1P's functions in cell migration and survival.
How do sphingolipids organize in cell membranes?
Sphingolipids contribute to lipid rafts, cholesterol- and sphingolipid-rich domains that facilitate signal transduction. Simons and Toomre (2000) in "Lipid rafts and signal transduction" explained rafts' role in organizing signaling molecules. Brown and London (1998) in "FUNCTIONS OF LIPID RAFTS IN BIOLOGICAL MEMBRANES" described detergent-resistant membranes containing sphingolipids.
What is the current research volume on sphingolipid metabolism and signaling?
The field includes 32,051 works. Growth data over the past five years is not available. Studies span implications in cancer, apoptosis, and immune disorders.
Open Research Questions
- ? How do sphingolipid gradients precisely control lymphocyte egress timing in immune responses?
- ? What mechanisms link ceramide accumulation to insulin resistance in metabolic diseases?
- ? How do sphingosine kinase inhibitors selectively target cancer cells without affecting normal apoptosis?
- ? What structural features of lipid rafts modulate sphingolipid signaling efficiency?
- ? How does S1P receptor modulation by fingolimod influence long-term neuroprotection in multiple sclerosis?
Recent Trends
The field maintains 32,051 works with no specified five-year growth rate.
High-citation papers from 1998-2013, such as Simons and Toomre with 6168 citations and Kappos et al. (2010) with 2593 citations, indicate sustained interest in lipid rafts and fingolimod applications.
2000No recent preprints or news coverage available.
Research Sphingolipid Metabolism and Signaling with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Sphingolipid Metabolism and Signaling with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers